Aardvark Therapeutics, Inc. Balance Sheet
Aardvark Therapeutics, Inc.'s total assets for Q3 2025 were $133.23M, a decrease of -9.66% from the previous quarter. AARD total liabilities were $10.85M for the fiscal quarter, a 2.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.